News
Hosted on MSN1mon
Ono earmarks $940m to gain rare blood cancer therapy from IonisThe PV field is not without US Food and Drug Administration ... another big-dollar deal last year for Ono, which licensed an antibody-drug conjugate (ADC) from LigaChem Biosciences for up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results